Your session is about to expire
← Back to Search
Artificial Intelligence
A Prospective Randomized Study Comparing the Adenoma Detection Yield of SC, AI and Combined AI and G-EYE®
N/A
Waitlist Available
Led By Douglad K Rex, MD
Research Sponsored by Smart Medical Systems Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up upon histology results (up to 30 days)
Awards & highlights
No Placebo-Only Group
Summary
This trial compares three methods of performing a colonoscopy to see which one finds more abnormal growths. The methods include a standard procedure, one with computer assistance, and one with both computer assistance and a special balloon. The goal is to find out which method is best at detecting growths that could lead to cancer.
Eligible Conditions
- Adenoma
- Improving Adenoma Detection Rate
- Colorectal Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ upon histology results (up to 30 days)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~upon histology results (up to 30 days)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adenoma Per Colonoscopy (APC) (AI compared with AG)
Secondary study objectives
Adenoma Per Colonoscopy (APC) (SC compared with AG)
Advanced Adenoma Per Colonoscopy (AAPC) (SC compared with AG)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Combined Artificial Intelligence (GI Genius™) and G-EYE® Colonoscopy (AG)Experimental Treatment1 Intervention
Subjects enrolled to arm 3 ("AG") will undergo colonoscopy using the G-EYE® Colonoscope and Artificial Intelligence Aided Colonoscopy (GI Genius™).
Group II: Standard Colonoscopy ("SC")Active Control1 Intervention
Subjects enrolled to arm 1 ("SC") will undergo colonoscopy using a standard colonoscope.
Group III: Artificial Intelligence Aided Colonoscopy (GI Genius™) ("AI")Active Control1 Intervention
Subjects enrolled to arm 2 ("AI") will undergo colonoscopy using a standard colonoscope aided by Artificial Intelligence (GI Genius™)
Find a Location
Who is running the clinical trial?
Smart Medical Systems Ltd.Lead Sponsor
8 Previous Clinical Trials
2,066 Total Patients Enrolled
6 Trials studying Adenoma
1,956 Patients Enrolled for Adenoma
Douglad K Rex, MDPrincipal InvestigatorIndina University